(Q37810261)

23 August 2017

title

Ischemia modified albumin changes - review and clinical implications (English)

1 reference

23 August 2017

Eftihia Sbarouni

1

1 reference

23 August 2017

Panagiota Georgiadou

series ordinal

2

1 reference

23 August 2017

Vassilis Voudris

series ordinal

3

1 reference

23 August 2017

publication date

18 November 2010

1 reference

Clinical Chemistry and Laboratory Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

49

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

177-184

1 reference

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Biomarkers of cardiovascular damage and dysfunction--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Oxidative and nitrosative stress in acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Evaluation of cardiac laboratory markers in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Effects of peripheral vascular intervention on ischemia-modified albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Effect of deep vein thrombosis on ischaemia-modified albumin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

The cobalt-albumin binding assay: insights into its mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Standardization of ischemia-modified albumin testing: adjustment for serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin during skeletal muscle ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

The PRIMA study: presentation ischaemia-modified albumin in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

The influence of exercise upon cardiac biomarkers: a practical guide for clinicians and scientists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia modified albumin in relation to pharmacologic stress testing in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

The ischemia-modified albumin in relation to pacemaker and defibrillator implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Value of ischemia-modified albumin in the diagnosis of pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischaemia-modified albumin in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Increased ischaemia modified albumin following coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Evaluation of cardiac involvement following major orthopedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Early diagnosis of myocardial infarction with sensitive cardiac troponin assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.037

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.037

1 reference

23 August 2017

1 reference